Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial

Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry, Olaf Valverde Mordt, Digas Ngolo Tete, Adeline Prêtre, Sophie Delhomme, Médard Ilunga Wa Kyhi, Mamadou Camara, Julie Catusse, Stefan Schneitter, Morgane Nusbaumer, Erick Mwamba Miaka, Hélène Mahenzi Mbembo, Joseph Makaya Mayawula, Mariame Layba Camara, Félix Akwaso Massa, Lewis Kaninda Badibabi, Augustin Kasongo Bonama, Papy Kavunga Lukula, Sylvain Mutanda Kalonji, Phyll Mariero Philemon, Ricardo Mokilifi Nganyonyi, Hugues Embana Mankiara, André Asuka Akongo Nguba, Vincent Kobo Muanza, Ernest Mulenge Nasandhel, Aimée Fifi Nzeza Bambuwu, Bruno Scherrer, Nathalie Strub-Wourgaft, Antoine Tarral

Open source

DOI: 10.1016/s1473-3099(22)00660-0
Published: 2023-04
Container: The Lancet Infectious Diseases
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-22-00660-0,
  title = {Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial},
  author = {Victor Kande Betu Kumeso and Wilfried Mutombo Kalonji and Sandra Rembry and Olaf Valverde Mordt and Digas Ngolo Tete and Adeline Prêtre and Sophie Delhomme and Médard Ilunga Wa Kyhi and Mamadou Camara and Julie Catusse and Stefan Schneitter and Morgane Nusbaumer and Erick Mwamba Miaka and Hélène Mahenzi Mbembo and Joseph Makaya Mayawula and Mariame Layba Camara and Félix Akwaso Massa and Lewis Kaninda Badibabi and Augustin Kasongo Bonama and Papy Kavunga Lukula and Sylvain Mutanda Kalonji and Phyll Mariero Philemon and Ricardo Mokilifi Nganyonyi and Hugues Embana Mankiara and André Asuka Akongo Nguba and Vincent Kobo Muanza and Ernest Mulenge Nasandhel and Aimée Fifi Nzeza Bambuwu and Bruno Scherrer and Nathalie Strub-Wourgaft and Antoine Tarral},
  year = {2023},
  journal = {The Lancet Infectious Diseases},
  doi = {10.1016/s1473-3099(22)00660-0},
  url = {https://doi.org/10.1016/s1473-3099(22)00660-0}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
AU  - Victor Kande Betu Kumeso
AU  - Wilfried Mutombo Kalonji
AU  - Sandra Rembry
AU  - Olaf Valverde Mordt
AU  - Digas Ngolo Tete
AU  - Adeline Prêtre
AU  - Sophie Delhomme
AU  - Médard Ilunga Wa Kyhi
AU  - Mamadou Camara
AU  - Julie Catusse
AU  - Stefan Schneitter
AU  - Morgane Nusbaumer
AU  - Erick Mwamba Miaka
AU  - Hélène Mahenzi Mbembo
AU  - Joseph Makaya Mayawula
AU  - Mariame Layba Camara
AU  - Félix Akwaso Massa
AU  - Lewis Kaninda Badibabi
AU  - Augustin Kasongo Bonama
AU  - Papy Kavunga Lukula
AU  - Sylvain Mutanda Kalonji
AU  - Phyll Mariero Philemon
AU  - Ricardo Mokilifi Nganyonyi
AU  - Hugues Embana Mankiara
AU  - André Asuka Akongo Nguba
AU  - Vincent Kobo Muanza
AU  - Ernest Mulenge Nasandhel
AU  - Aimée Fifi Nzeza Bambuwu
AU  - Bruno Scherrer
AU  - Nathalie Strub-Wourgaft
AU  - Antoine Tarral
PY  - 2023
JO  - The Lancet Infectious Diseases
DO  - 10.1016/s1473-3099(22)00660-0
UR  - https://doi.org/10.1016/s1473-3099(22)00660-0
ER  -

APA

Kumeso, V. K. B., Kalonji, W. M., Rembry, S., Mordt, O. V., Tete, D. N., Prêtre, A., Delhomme, S., Kyhi, M. I. W., Camara, M., Catusse, J., Schneitter, S., Nusbaumer, M., Miaka, E. M., Mbembo, H. M., Mayawula, J. M., Camara, M. L., Massa, F. A., Badibabi, L. K., Bonama, A. K., Lukula, P. K., Kalonji, S. M., Philemon, P. M., Nganyonyi, R. M., Mankiara, H. E., Nguba, A. A. A., Muanza, V. K., Nasandhel, E. M., Bambuwu, A. F. N., Scherrer, B., Strub-Wourgaft, N., & Tarral, A. (2023). Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(22)00660-0

Source records

crossref · retrieved 2026-09-26T23:02:39.175Z